Our study underscores the important role of miR-491-5p in GC progression, and we expect that our findings for the Foxi1/miR-491-5p/Wnt3a/β-catenin signaling axis will provide useful information for the development of more effective and promising therapies against GC. The gene discussed is FOXI1; the disease is gastric cancer.